Beam Therapeutics Inc.
$BEAM
Public valuation for Beam Therapeutics Inc. (BEAM). Fair value, signal, and key metrics — no sign-in required.
Current Price
$25.52
36% Overvalued
Fair Value Estimate
$16
🚧
Turnaround
Negative earnings but showing signs of recovery
Analyst Consensus
Target: $52.31
105% higher than current
Key Metrics
Market Cap
$2.6B
Operating Margin
-337.8%
Revenue Growth
200.2%
Get free watchlist alerts
Join the waitlist for valuation updates on $BEAM and the rest of your watchlist.
Join the waitlistJoin the waitlist
Stay on this page to join — no sign-in required.